These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 579063)
61. Analogs of phenothiazines. 5. Synthesis and neuropharmacological activity of some piperidylidene derivatives of thioxanthenes, xanthenes, dibenzoxepins, and acridans. Kaiser C; Fowler PJ; Tedeschi DH; Lester BM; Garvey E; Zirkle CL J Med Chem; 1974 Jan; 17(1):57-62. PubMed ID: 4808470 [No Abstract] [Full Text] [Related]
62. Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity. Arnt J; Christensen AV; Hyttel J; Larsen JJ; Svendsen O Eur J Pharmacol; 1982 Dec; 86(2):185-98. PubMed ID: 6130958 [No Abstract] [Full Text] [Related]
63. Prolonged neuroleptic effect of alpha-flupenthixol decanoate in oil. Nymark M; Franck KF; Pedersen V; Boeck V; Nielsen IM Acta Pharmacol Toxicol (Copenh); 1973; 33(5):363-76. PubMed ID: 4801082 [No Abstract] [Full Text] [Related]
64. Behavioural and biochemical changes following chronic administration of L-dopa to rats. Pycock C; Dawbarn D; O'Shaughnessy C Eur J Pharmacol; 1982 Apr; 79(3-4):201-15. PubMed ID: 7201400 [TBL] [Abstract][Full Text] [Related]
65. Pharmacological studies on triazine derivatives V Sedative and neuroleptic actions of 2-amino-4-[4-(2-hydroxyethyl)-piperazin-1-yl]-6-trifluoromethyl-s-triazine (TR-10). Tobe A; Kobayashi T Jpn J Pharmacol; 1976 Oct; 26(5):559-70. PubMed ID: 12393 [TBL] [Abstract][Full Text] [Related]
66. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Arnt J; Hyttel J; Sánchez C Eur J Pharmacol; 1992 Mar; 213(2):259-67. PubMed ID: 1355737 [TBL] [Abstract][Full Text] [Related]
67. Influences of diterpene sclareol glycol on some dopamine related behavior. Georgieva JV Gen Pharmacol; 1991; 22(2):331-5. PubMed ID: 2055429 [TBL] [Abstract][Full Text] [Related]
68. AHR-6646: a new, long-acting neuroleptic. Johnson DN; Turley BG; Jones MR; Coffin CB; Leonard CA; Funderburk WH Prog Neuropsychopharmacol; 1979; 3(5-6):513-20. PubMed ID: 45570 [TBL] [Abstract][Full Text] [Related]
69. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol. Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610 [TBL] [Abstract][Full Text] [Related]
70. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors. Vasse M; Protais P Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186 [TBL] [Abstract][Full Text] [Related]
71. The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug. Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Verbruggen FJ; van Nueten JM; Marsboom RH; Hérin VV; Schaper WK Arzneimittelforschung; 1970 Nov; 20(11):1689-98. PubMed ID: 4992598 [No Abstract] [Full Text] [Related]
72. Dopaminergic mechanisms in the teleost retina. I. Dopamine-sensitive adenylate cyclase in homogenates of carp retina; effects of agonists, antagonists, and ergots. Watling KJ; Dowling JE J Neurochem; 1981 Feb; 36(2):559-68. PubMed ID: 6109764 [TBL] [Abstract][Full Text] [Related]
73. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine]. Mikhaĭlova TV; Terekhina AI; Gilev AP Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895 [No Abstract] [Full Text] [Related]
75. Long term effect of teflutixol on apomorphine-induced stereotypy and vomiting in dogs. Svendsen O Eur J Pharmacol; 1979 Feb; 53(4):387-90. PubMed ID: 570504 [TBL] [Abstract][Full Text] [Related]
76. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia. Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086 [TBL] [Abstract][Full Text] [Related]
77. Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Crawford CA; McDougall SA; Meier TL; Collins RL; Watson JB Psychopharmacology (Berl); 1998 Mar; 136(1):34-43. PubMed ID: 9537680 [TBL] [Abstract][Full Text] [Related]
78. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Christensen AV; Arnt J; Hyttel J; Larsen JJ; Svendsen O Life Sci; 1984 Apr; 34(16):1529-40. PubMed ID: 6144029 [TBL] [Abstract][Full Text] [Related]
79. The neuropharmacological actions of amoxapine. Greenblatt EN; Lippa AS; Osterberg AC Arch Int Pharmacodyn Ther; 1978 May; 233(1):107-35. PubMed ID: 28699 [TBL] [Abstract][Full Text] [Related]
80. Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study. Worms P; Kan JP; Wermuth CG; Biziere K Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):246-52. PubMed ID: 3100965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]